Ekokobe Fonkem, DO
Neurology · Johnstown, PANPI 1538359534
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $13,700 of the $18,247 with a category attached, or 75.1%. 9 manufacturers reported payments, led by Servier Pharmaceuticals LLC at 48.1% of the total. Reporting peaked in 2024 at $9,342 and has fallen 98.1% since, to $174 in 2025.
Across 68 payments — averaging $268.33 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Servier Pharmaceuticals LLC$9K
- Novocure Inc.$7K
- Bayer$1K
- Monteris Medical Corporation$561
- GT Medical Technologies, Inc$370
- AbbVie$192
- plus $135 from 3 others
Across 51 payments — averaging $3467.53 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- AbbVie$128K
- Agios Pharmaceuticals, Inc.$31K
- Servier Pharmaceuticals LLC$9K
- Novocure Inc.$5K
- Genentech, Inc.$3K
What the payments were for
- Consulting fees$13,70075%
- Travel & lodging$1101%
- Food & beverage$4,43724%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Servier Pharmaceuticals LLC | 5 | $8,782 |
| Novocure Inc. | 44 | $7,175 |
| Bayer | 3 | $1,032 |
| Monteris Medical Corporation | 6 | $561 |
| GT Medical Technologies, Inc | 5 | $370 |
| AbbVie | 2 | $192 |
| Caris MPI, Inc. | 1 | $91 |
| TG Therapeutics, Inc. | 1 | $25 |
| Masimo Corporation | 1 | $20 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$18,247 in reported general payments places this provider in the 80th percentile of 941 neurology providers in Pennsylvania.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Levetiracetam | 31 | $1,379 |
Paid to pharmacies, not to this prescriber.
Other neurology in Johnstown
- Nicholas LancianoJohnstown$198K
- Daniel KremensPhiladelphia$1.8M
- Thomas LeistPhiladelphia$1.4M
- Jill Giordano FarmerPhiladelphia$1.2M
- Ravi DukkipatiYork$936K
- Brad KleinAbington$927K
- Stephanie Nahas-GeigerPhiladelphia$786K
- John KhouryAbington$686K
- Amit Bar-OrPhiladelphia$596K
- Behrang SaminejadAllentown$594K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.